Skip to content

DELIRIUM SCREENING, INCIDENCE AND MANAGEMENT OBSERVATIONAL STUDY IN 2024 - THE CZECH REPUBLIC

DELIRIUM SCREENING, INCIDENCE AND MANAGEMENT OBSERVATIONAL STUDY IN 2024 - THE CZECH REPUBLIC

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05841368
Acronym
DELUSION
Enrollment
2000
Registered
2023-05-03
Start date
2024-01-01
Completion date
2024-07-31
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium

Keywords

Delirium, Screening, Therapy, CAM-ICU

Brief summary

Delirium in intensive care unit (ICU) settings is a frequent complication with reported prevalence of 31%. Recent data has revealed the connection between delirium and increased 30days mortality after hospital release and the higher incidence of readmission to emergency. Despite the high prevalence and well described validation methods for screening, the precise incidence remains unclear due to insufficient screening in ICU settings. The incidence of delirium in Czech Republic remains undescribed, beside data reported from neurointensive care patients and single-center general critically ill patients data.

Detailed description

All patients fulfilling inclusion criteria in intensive care settings in involved ICUs in Czech Republic will be included into the study. Data will be recorded for 1 consequent month. Basic demography will be evaluated. In each patient standard delirium screening based on the institutional ICU rules will be performed. If no screening method were set,Confusion Assessment Method - CAM-ICU for adult and pediatric Confusion Assessment Method -pCAM-ICU for pediatric patients would be used together with delirium management, restrain procedures, sedative/neuroleptics administration, 28-days mortality. All data will be recorded into to predefined eCRF.

Interventions

DIAGNOSTIC_TESTCAM-ICU

Delirium in adult patients will be screened according to CAM-ICU

DIAGNOSTIC_TESTpCAM-ICU

Delirium in adult patients will be screened according to pCAM-ICU

Sponsors

Masaryk University
CollaboratorOTHER
Department of Neurology, University Hospital Brno
CollaboratorUNKNOWN
Brno University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients in ICU settings * in defined time interval of the study

Exclusion criteria

* duration of ICU stay shorter than 24 hours

Design outcomes

Primary

MeasureTime frameDescription
Delirium prevalenceduring 30 days after study initiation in selected ICUDelirium prevalence by CAM-ICU and pCAM-ICU will be screened in defined time interval

Secondary

MeasureTime frameDescription
Delirium managementduring 30 days after study initiation in selected ICUManagement of delirium will be evaluated
Inhospital mortalityduring 30 days after study initiation in selected ICUInhospital mortality will be evaluated
28-days mortalityafter patient inclusion into the study28-days mortality will be evaluated
90-days mortalityafter patient inclusion into the studylong term mortality will be evaluated

Countries

Czechia

Contacts

Primary ContactJozef UO Klučka, assoc.prof.MD., Ph.D.
klucka.jozef@fnbrno.cz+420532234696
Backup ContactJan Malaska, MD.PHD. EDIC
malaska.jan@fnbrno.cz+420532234695

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026